Jump to:
loading...| Preferred Name |
rapacuronium |
|
| Synonyms |
Raplon Org-9487 Org 9487 1-allyl-1-(3alpha,17beta-dihydroxy-2beta-piperidino-5alpha-androstan-16beta-yl)piperidinium, 3-acetate 17-propionate rapacuronium bromide |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C082938 |
|
| altLabel |
Raplon Org-9487 Org 9487 1-allyl-1-(3alpha,17beta-dihydroxy-2beta-piperidino-5alpha-androstan-16beta-yl)piperidinium, 3-acetate 17-propionate rapacuronium bromide |
|
| cui |
C0753790 C0219598 C0876716 C0876147 |
|
| Has mapping qualifier | ||
| HM |
D014673/Q000031 |
|
| Inverse of RB |
GG1LBM463S 0 65Q4QDG4KC |
|
| isa | ||
| LT |
TRD |
|
| Mapped to | ||
| MDA |
19930928 |
|
| MeSH Frequency |
111 |
|
| MMR |
20170626 |
|
| notation |
C082938 |
|
| PA |
D003473 |
|
| prefLabel |
rapacuronium |
|
| RR |
65Q4QDG4KC |
|
| SC |
1 |
|
| Scope Statement |
16-N-allyl-17-beta-propionate analog of vecuronium; structure given in first source |
|
| SRC |
Anesth Analog 1993 Sep;77(3):579-84 |
|
| TERMUI |
T250831 T466313 T250829 T419979 T250830 |
|
| TH |
US NLM (2000) NLM (1993) FDA SRS (2017) USAN (19XX) INN (19XX) |
|
| tui |
T109 T121 |
Create mapping